(Q40948411)

25 September 2017

Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis (English)

1 reference

25 September 2017

1 reference

4

H Marzo-Ortega

0 references

author name string

M Rudwaleit

1

1 reference

25 September 2017

J T Rosenbaum

2

1 reference

25 September 2017

R Landewé

3

1 reference

25 September 2017

J Sieper

5

1 reference

25 September 2017

D van der Heijde

6

1 reference

25 September 2017

O Davies

7

1 reference

25 September 2017

H Bartz

8

1 reference

25 September 2017

B Hoepken

9

1 reference

25 September 2017

T Nurminen

10

1 reference

25 September 2017

A Deodhar

11

1 reference

25 September 2017

27 January 2016

1 reference

Arthritis Care and Research

25 September 2017

1 reference

25 September 2017

68

1 reference

25 September 2017

6

1 reference

25 September 2017

838-844

1 reference

Efficacy of anti-tumor necrosis factor therapy for extra-articular manifestations in patients with ankylosing spondylitis: a meta-analysis

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Management and evaluation of extra-articular manifestations in spondyloarthritis

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Comorbidities in patients with spondyloarthritis

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Spondyloarthritis: the eyes have it: uveitis in patients with spondyloarthritis

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

The burden of ankylosing spondylitis.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Anti-TNF therapy for eye involvement in spondyloarthropathy

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Visual functioning and general health status in patients with uveitis.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5089650

Certolizumab Pegol, a New Anti-TNF-α in the Armamentarium against Ocular Inflammation

19 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FACR.22848

Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis

21 January 2018

1 reference

12 December 2020

Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors

1 reference

12 December 2020

Do tumor necrosis factor inhibitors cause uveitis? A registry-based study

1 reference

12 December 2020

New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases

1 reference

12 December 2020

Methotrexate: an option for preventing the recurrence of acute anterior uveitis

1 reference

12 December 2020

[Prevention of acute anterior uveitis associated with spondylarthropathy induced by salazosulfapyridine]

1 reference

12 December 2020

Identifiers

DOI

10.1002/ACR.22848

1 reference

25 September 2017

1 reference

25 September 2017

PubMed publication ID

26815944

1 reference